{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:32:00Z","timestamp":1746325920488},"reference-count":0,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z Gastroenterol"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Das diffuse maligne peritoneale Mesotheliom (DMPM) ist eine seltene Diagnose. Es tritt h\u00e4ufiger bei M\u00e4nnern als bei Frauen auf. Die Symptome sind vor allem unspezifische abdominelle Beschwerden, was die Diagnosestellung erschwert. Die Ursachen des DMPM sind noch nicht ausreichend gekl\u00e4rt. Ca. 7\u200a% der peritonealen Mesotheliome lassen sich auf eine Asbestexposition zur\u00fcckf\u00fchren. Das DMPM war bis zur Entwicklung des Therapiekonzepts der systematischen chirurgischen Zytoreduktion (CRS) und anschlie\u00dfenden hyperthermen intraperitonealen Chemotherapie (HIPEC) eine fatale Diagnose mit einer medianen Lebenserwartung von 4\u201313 Monaten. Mit der CRS und HIPEC verbesserte sich die Prognose des DMPM deutlich auf 30\u201392\u00a0Monate heutzutage. Das vorliegende Fallbeispiel stellt die heute m\u00f6gliche Therapie und deren Ergebnisse vor.<\/jats:p>","DOI":"10.1055\/a-1083-6962","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:46:40Z","timestamp":1581554800000},"page":"146-151","source":"Crossref","is-referenced-by-count":3,"title":["Das diffuse maligne peritoneale Mesotheliom (DMPM) \u2013 eine seltene Diagnose"],"prefix":"10.1055","volume":"58","author":[{"given":"Victoria Susanne Antonia","family":"Habbel","sequence":"additional","affiliation":[{"name":"Asklepios Campus Hamburg, Medizinische Fakult\u00e4t der Semmelweis Universit\u00e4t, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa Annabelle","family":"Mahler","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Allgemein- und Viszeralchirurgie, chirurgische Onkologie, Asklepios Klinik Barmbek, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Feyerabend","sequence":"additional","affiliation":[{"name":"MVZ Hanse Histologikum GmbH, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-J\u00fcrgen","family":"Oldhafer","sequence":"additional","affiliation":[{"name":"Asklepios Campus Hamburg, Medizinische Fakult\u00e4t der Semmelweis Universit\u00e4t, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Josef","family":"Lipp","sequence":"additional","affiliation":[{"name":"Asklepios Campus Hamburg, Medizinische Fakult\u00e4t der Semmelweis Universit\u00e4t, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2020,2,12]]},"container-title":["Zeitschrift f\u00fcr Gastroenterologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1083-6962.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:46:59Z","timestamp":1581554819000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1083-6962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":0,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2020,2,12]]},"published-print":{"date-parts":[[2020,2]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1083-6962","relation":{},"ISSN":["0044-2771","1439-7803"],"issn-type":[{"value":"0044-2771","type":"print"},{"value":"1439-7803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}